Elese Hanson

Elese Hanson

Katten Muchin Rosenman LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

FDA Issues Two Additional Draft Guidance Documents on Social Media

On June 17, 2014, the US Food and Drug Administration (FDA) released two additional draft guidance documents relating to the pharmaceutical industry's use of social media. One of the guidance documents addresses how...more

7/9/2014 - Corporate Counsel FDA Pharmaceutical Popular Social Media User-Generated Content

Supreme Court Unanimously Rejects Federal Circuit Standards for Indefiniteness and Induced Infringement

The US Supreme Court issued two anticipated decisions on June 2, 2014, relating to the US Court of Appeals for the Federal Circuit's standards for indefiniteness and induced infringement. In the first, Nautilus, Inc....more

6/9/2014 - Definiteness Indefiniteness Induced Infringement Infringement Nautilus Inc. v. Biosig Instruments Patent Infringement Patent Litigation Patents SCOTUS

Draft FDA Guidance on Real-Time Promotional Statements Made Via Social Media

In January 2014, the US Food and Drug Administration (FDA) gave the pharmaceutical industry another glimpse of its thinking on social media marketing. The agency’s draft guidance, titled “Fulfilling Regulatory Requirements...more

3/12/2014 - Contests & Promotions FDA Pharmaceutical Social Media

3 Results
|
View per page
Page: of 1